Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of the Tolerability and Clinical Effectiveness of Letermovir When Used for Secondary Prophylaxis to Prevent Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

NCT05626530 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT05626530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05626530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of the Tolerability and Clinical Effectiveness of Letermovir When Used for Secondary Prophylaxis to Prevent Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
Lead sponsor
Tufts Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
February 2, 2023
Completion date
December 15, 2025
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral toxicity, cytomegalovirus infections, infection in solid organ transplant recipients, neutropenia